International stock news

Rss Today on Proactive AU

2014-11-26

Imugene is undervalued v ASX, global peers in Immuno-Oncology

 
Imugene is an immuno-oncology company developing B-cell based immunotherapies. Immunotherapy has become one of the hottest and most promising areas of study for the treatment of a variety of cancerous tumours. Pfizer and Merck will JV on up to 20 preclinical immuno-oncology programs in 2015.
FULL ARTICLE

 

Rss Today on Proactive UK

2014-11-26

ASOS, Quindell sell-offs weigh on AIM market

 
Swift and severe sell-offs in some of AIM’s largest stocks has taken its toll on the UK’s junior market in recent months. High profile small-cap constituents ASOS (LON:ASC), Quindell (LON:QPP) and Blinx (LON:BLNX) have been all ditched by investors after hitting trouble.  
FULL ARTICLE

 

Rss Today on Proactive US

2014-11-26

Wall Street ends mixed, oil falls to four-year low

 
U.S. stocks came under pressure Tuesday after a mixed bag of economic reports, including a disappointing consumer confidence report for November.
FULL ARTICLE